253D%26d%3DDwMFAg%26c%3DAnw7wICLFSGyH7zEzlqo-zgMRy5HE-AH- SibmOy3H7xE%26&/03Dz3qSdxmKEzz6GPGylfF- 3_Hq7hsd5IK6Msil28sD12s%26m%3DReH187Lo8GfZx7aE2WwyLLYGKETXifodokdng9nMbyQ%26s%3Dr NJ0fcA4DmP6v-LanqWQLToal-5gCKcijX-hBWEeZvg%26e%3D> From: mailto: > Sent: Thursda October 22 2020 10:33 AM To: >; McGorty, Glen Cc: Zelenko, Daniel >; Giffuni, Danielle (USANYS) Subject: RE: Wednesdays WebEx External Email Glen, As I believe we mentioned when we last spoke, we would like to schedule time for a second interview with Mr. via WebEx. Are there any days the week of November 9th when your team and Mr. would be available? We would expect this proffer to be much shorter than our first, and certainly no more than two hours at most. Thanks, Assistant United States Attorney Southern District of New York mailto: From: l== ) alMIE<mailto:a> Sent: Friday, October 9 2020 4:42 PM To: McGorty, Glen • mailto: Cc: Zelenko, Daniel • mailto mailto: mailto mailto: Subject: RE: Wednesdays WebEx Hi Glen, Thanks very much. I'm attaching the fully executed copy. Thanks, >; Giffuni, Danielle USANYS From: McGorty, Glen ail <rnailto:a> EFTA00024946

Sent: Thursda To: Cc: Zelenko, Daniel October 8, 2020 9:31 AM mailto: mailto mailto: Subject: RE: Wednesday's WebEx Hi all. mailto: mailto: >; Giffuni, Danielle SANYS Attached please find the signed proffer agreement. It was nice seeing everyone yesterday. Thanks, Glen Glen G. McGorty I Crowell & Moring LLP Managing Partner, New York Office mailto: I https://protect2.fireeye.com/v1/url?k=da840e91- 851 f3661-da832a74-ac 1 f6b0176b0-58804d78c5a0bd83&q= 1 &e= 1 d 1 e9fd4-963c-4f0c-9030- fa571a9724ea&u=http%3A%2F%2Fvvww.crowell.com%2F<https://protect2.fireeye.com/v1/url?k=050f7ecc- 5a94463c-05085a29-aclf6b0176b0-922128737facObb3&q=l&e=1d1 e9fd4-963c-4f0c-9030- fa571a9724ea&u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhups- 3A_protect2.fireeye.com_vl_ur1-3Fk-3Da7a67447-2Df83d4cb7-2Da7a150a2-2Daclf6b01744c- 2Db0490c85237ea2a6-26q-3D1-26e-3D83d2ee7c-2Db93e-2D4e2b-2Daa44-2Da878fdb13980-26u-3Dhttps- 253A-252F-252Furldefense.proofpoint.com-252Fv2-252Fur1-253Fu-253Dhttps-2D3A-5F- 5Fprotect2.fireeye.com-5Fv1-5Fur1-2D3Fk-2D3Dc59cf924-2D2D9a07c068-2D2Dc59bddc1- 2D2DOcc47adca7cc-2D2Decb7a8a4b62bca59-2D26q-2D3D1-2D26e-2D3D6f706ce0-2D2De9c6-2D2D4b08- 2D2Da64c-2D2D2f358da88751-2D26u-2D3Dhttps-2D253A-2D252F-2D252Furldefense.proofpoint.com- 2D252Fv2-2D252Fur1-2D253Fu-2D253Dhttps-2D2D3A-2D5F-2D5Fprotect2. fireeye.com-2D5Fv1-2D5Furl- 2D2D3Fk-2D2D3Dacc430f1-2D2D2Df0a8d931-2D2D2Dacc31414-2D2D2D0cc47adca7dc- 2D2D2D1816b4788e84celd-2D2D26q-2D2D3D1-2D2D26e-2D2D3Dd4822d00-2D2D2Dd7d4-2D2D2D4ab8- 2D2D2D889b-2D2D2D5b73ff4e1b2a-2D2D26u-2D2D3Dhttp-2D2D253A-2D2D252F- 2D2D252Fwww.crowell.com-2D2D252F-2D2526d-2D253DDwMFAg-2D2526c- 2D253DAnw7wICLFSGyH7zEzlqo-2D2DzgMRy5HE-2D2DAH-2D2DSibmOy3H7xE-2D2526r- 2D253Dz3qSdxmICBzz6GPGylfF-2D2D3-2D5FHq7hsd51K6Msil28sD12s-2D2526m-2D253D5KU6Aw- 2D5FMkC4e0JV1m-2D2D-2D5FQS8CjCeik4belz9SriYKO5tY-2D2526s-2D253DUGSmV2OCvqehSfQAW- 2D2DhUdeHBpiQlat6EOfe4t4AFFY-2D2526e-2D253D-2526d-253DDwMFAg-2526c- 253DAnw7w1CLFSGyH7zEzlqo-2DzgMRy5HE-2DAH-2DSibmOy3H7xE-2526r- 253Dz3qSdxmICBzz6GPGylfF-2D3-5FHq7hsd51K6MsiI28sD12s-2526m-253DBxYgAU783n- 5FMrr2q5wLWEF-2DW5qCINJ5632-2DFFn3T1GQ-2526s-253DzL38XpzcBLJrnxMcaiNc3rK4Ls- 5F5te3ERNgJePwlmCs-2526e-253D%26d%3DDwMFAg%26c%3DAnw7wKLFSGyH7zEzlqo-zgMRy5HE- AH-SibmOy3H7xE%26r%3Dz3qSdzinKBzz6GPGylfF- 3_Hq7hsd5IK6Msil28sDI2s%26m%3DReH187Lo8GfZx7aE2WwyLLYGKETXifodokdng9nMbyQ%26s%3Dq wZJFGsMRAfitn347SaVB0b3-BhdT1Onqn5XKtDrH2Wg%26e%3D> I Web Bio<https://protect2.fireeye.com/v1/url?k=88febld3-d7658923-88199536-aclf6b0176b0- edb72c3da9f237dc&q= 1 &e= 1 d 1 e9fd4-963c-4ffic-9030- fa571a9724ea&u=hups%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps- 3A_protect2.fireeye.com_vl_ur1-3Fk-3D73c45499-2D2c5f6c69-2D73c3707c-2Daclf6b01744c- 2Df7fcc94a5b98b74a-26q-3D I -26e-3D83d2ee7c-2Db93e-2D4e2b-2Daa44-2Da878fdb13980-26u-3Dhttps- 253A-252F-252Furldefense.proofpoint.com-252Fv2-252Fur1-253Fu-253Dhttps-2D3A-5F- 5Fprotect2.fireeye.com-5Fv1-5Fur1-2D3Fk-2D3Dd3f6a98b-2D2D8c6d90c7-2D2Dd3f18d6e- 2D2DOcc47adca7cc-2D2D909299b600915616-2D26q-2D3D1-2D26e-2D3D6f706ce0-2D2De9c6-2D2D4b08- EFTA00024947

2D2Da64c-2D2D2f358da88751-2D26u-2D3Dhrips-2D253A-2D252F-2D252Furldefense.proofpoint.com- 2D252Fv2-2D252Fur1-2D253Fu-2D253Dhttps-2D2D3A-2D5F-2D5Fprotect2.fireeye.com-2D5Fv1-2D5Fur1- 2D2D3Fk-2D2D3Dc3a13be2-2D2D2D9fcdd222-2D2D2Dc3a61f07-2D2D2D0cc47adca7dc- 2D2D2Dd2eaef5d2d8fa6b1-2D2D26q-2D2D3D1-2D2D26e-2D2D3Dd4822d00-2D2D2Dd7d4-2D2D2D4ab8- 2D2D2D889b-2D2D2D5b73ff4e1b2a-2D2D26u-2D2D3Dhttps-2D2D253A-2D2D252F- 2D2D252Fwww.crowell.com-2D2D252Fprofessionals-2D2D252FGlen-2D2D2DMcGorty-2D2526d- 2D253DDwMFAg-2D2526c-2D253DAnw7wICLFSGyH7zEzIqo-2D2DzgMRy5HE-2D2DAH- 2D2DSibmOy3H7xE-2D2526r-2D253Dz3qSdxmICBzz6GPGylfF-2D2D3-2D5FHq7hsd51K6Msil28sD12s- 2D2526m-2D253D5KU6Aw-2D5FMkC4e0JVIm-2D2D-2D5FQS8CjCeik4belz9SriYKO5tY-2D2526s- 2D253DWjXvoekj-2D2DMGpon,ICrTVIUFMZALP9qSKGErNlwrnMAU1Q-2D2526e-2D253D-2526d- 253DDwMFAg-2526c-253DAnw7wKLFSGyH7zEzIqo-2DzgMRy5HE-2DAH-2DSibmOy3H7zE-2526r- 253Dz3qSdxmICBzz6GPGylfF-2D3-5FHq7hsd51K6Msi128sD12s-2526m-253DBxYgAU783n- 5FMrr2q5wLWEF-2DW5qCINJ5632-2DFFn3T1GQ-2526s- 253DctYL6hrMgDyLloWglikZXbArFtmzedOzeeCBfrbV7hgzI-2526e- 253D%26d%3DDwMFAg%26c%3DAnw7wKLFSGyH7zEzlqo-zgMRy5HE-AH- SibmOy3H7xE%26&/03Dz3qSdxmKEzz6GPGylfF- 3_Hq7hsd5IK6Msil28sD12s%26m%3DReH187Lo8Gfa7aE2WwyLLYGKETXifodokdng9nMbyQ%26s%3D9 ZTygQPqd8k8sRAmFcFoWdm2WnL5tumFv4zLZRIU3MQ%26e%3D> Privileged and Confidential • Attorney-Client Communication • Attorney Work Product This message contains privileged and confidential information. IF IT WAS SENT TO YOU BY MISTAKE, DO NOT READ IT. Instead, please notify the sender (or [email protected]<mailto:[email protected]>) by reply e- mail, and delete this e-mail. Unauthorized dissemination, forwarding or copying of this e-mail is strictly prohibited. COVID-19 Questions or Concerns? See Crowell & Moring's COVID-19 Resource Center<https://protect2.fireeye.com/v1/url?k=a5e2e9e2-fa79d112-a5e5cd07-aclf6b0176b0- 985e4f7e982ffae6&q=1&e=ldle9fd4-963c-4f0c-9030- fa571a9724ea&u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps- 3A_protect2.fireeye.com_vl_ur1-3Fk-3D5334050d-2DOcaf3dfd-2D533321e8-2Daclf6b01744c- 2D6c38b2lee877eddf-26q-3D1-26e-3D83d2ee7c-2Db93e-2D4e2b-2Daa44-2Da878fdb13980-26u-3Dhttps- 253A-252F-252Furldefense.proofpoint.com-252Fv2-252Furl-253Fu-253Dhttps-2D3A-5F- 5Fprotect2.fireeye.com-5Fv1-5Fur1-2D3F1c-2D3Dc033353e-2D2D9fa80c72-2D2Dc03411db- 2D2DOcc47adca7cc-2D2D81cf5c234441dfb2-2D26q-2D3D1-2D26e-2D3D6f706ce0-2D2De9c6-2D2D4b08- 2D2Da64c-2D2D2f358da88751-2D26u-2D3Dhttps-2D253A-2D252F-2D252Furldefense.proofpoint.com- 2D252Fv2-2D252Fur1-2D253Fu-2D253Dhttps-2D2D3A-2D5F-2D5Fprotect2.fireeye.com-2D5Fv1-2D5Fur1- 2D2D3Fk-2D2D3Ddfcc55d5-2D2D2D83a0bc15-2D2D2Ddfcb7130-2D2D2DOcc47adca7dc- 2D2D2D6Oacc515552e58df-2D2D26q-2D2D3D1-2D2D26e-2D2D3Dd4822d00-2D2D2Dd7d4-2D2D2D4ab8- 2D2D2D889b-2D2D2D5b73ff4e1b2a-2D2D26u-2D2D3Dhttps-2D2D253A-2D2D252F- 2D2D252Fwww.crowell.com-2D2D252FPractices-2D2D252FCoronavirus-2D2D2DCOVID-2D2D2D19- 2D2D2DResource-2D2D2DCenter-2D2526d-2D253DDwMFAg-2D2526c-2D253DAnw7w1CLFSGyH7zEzIqo- 2D2DzgMRy5HE-2D2DAH-2D2DSibm0y3H7xE-2D2526r-2D253Dz3qSdzmICBzz6GPGylfF-2D2D3- 2D5FHq7hsd51K6Msi128sD12s-2D2526m-2D253D5KU6Aw-2D5FMkC4e0JVIm-2D2D- 2D5FQS8CjCeik4belz9SriYKO5tY-2D2526s-2D253D5i-2D2DXX90Z2ithjJd2- 2D2DOeBRPyBkr2haDAJjyA5-2D2Dm93G81-2D2526e-2D253D-2526d-253DDwMFAg-2526c- 253DAnw7wKLFSGyH7zEzlqo-2DzgMRy5HE-2DAH-2DSibm0y3H7zE-2526r- 253Dz3qSdxmKBzz6GPGylfF-2D3-5FHq7hsd51K6Msi128sD12s-2526m-253DBxYgAU783n- 5FMrr2q5wLWEF-2DW5qCINJ5632-2DFFn3T1GQ-2526s-253Dre8-2DZyh- 5F3fEo21T 1 lzy4PAdCZBbHAy1RSBEJO5OwoZc-2526e- 253D%26d%3DDwMFAg%26c%3DAnw7w1CLFSGyH7zEzlqo-zgMRy5HE-AH- SibmOy3H7xE%26&/03Dz3qSdxmKEzz6GPGylfF- 3_Hq7hsd5IK6Msil28sD12s%26m%3DReH187Lo8Gfa7aE2WwyLLYGKETXifodokdng9nMbyQ%26s%3Dc SzLNIIXICW_Ir0HL8OSm2x1XtKPg9YzzhjusXy1Jaws2o%26e%3D> EFTA00024948